Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)

v3.21.2
Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Disaggregation of Revenue [Line Items]        
Total revenue $ 84,675 $ 41,420 $ 139,825 $ 74,581
Royalties        
Disaggregation of Revenue [Line Items]        
Total revenue 8,616 7,181 15,728 13,746
Kyprolis        
Disaggregation of Revenue [Line Items]        
Total revenue 5,440 5,481 9,727 9,886
Evomela        
Disaggregation of Revenue [Line Items]        
Total revenue 2,193 1,199 4,526 2,775
Other        
Disaggregation of Revenue [Line Items]        
Total revenue 983 501 1,475 1,085
Captisol        
Disaggregation of Revenue [Line Items]        
Total revenue 62,509 24,468 93,781 45,577
Contract revenue        
Disaggregation of Revenue [Line Items]        
Total revenue 13,550 9,771 30,316 15,258
Service Revenue        
Disaggregation of Revenue [Line Items]        
Total revenue 7,360 4,582 12,822 7,939
License Fees        
Disaggregation of Revenue [Line Items]        
Total revenue 1,050 660 2,093 1,635
Milestone        
Disaggregation of Revenue [Line Items]        
Total revenue 3,600 3,472 12,017 3,806
Other        
Disaggregation of Revenue [Line Items]        
Total revenue $ 1,540 $ 1,057 $ 3,384 $ 1,878